← back to search

Fangyi Yao

Nanchang University · CN
Area of research
Hematology · Cancer Research
Research interest
Research focused on Myeloid leukemia and Peripheral blood mononuclear cell, with related work in Mycobacterium tuberculosis, Immune system, Gene knockdown. Notable publications include 'Identification of Differentially Expressed Long Non-coding RNAs in Polarized Macrophages', 'Microarray Expression Profile of Circular RNAs in Peripheral Blood Mononuclear Cells from Active Tuberculosis Patients', and 'Up-regulation of circRNA-0003528 promotes mycobacterium tuberculosis associated macrophage polarization via down-regulating miR-224-5p, miR-324-5p and miR-488-5p and up-regulating...'.
h-index
citations
523
works
29
NIH funding
primary concept
email

Recent publications

ZCCHC4 regulates esophageal cancer progression and cisplatin resistance through ROS/c-myc axis
Scientific Reports 2025cited by 8position: middledoi
Integrated multiomics analysis and machine learning refine neutrophil extracellular trap-related molecular subtypes and prognostic models for acute myeloid leukemia
Frontiers in Immunology 2025cited by 8position: middledoi
METTL5 regulates SEPHS2-mediated selenoprotein synthesis to promote multiple myeloma survival and progression
Cell Death and Disease 2025cited by 4position: middledoi
The role of METTL14 in the progression of chronic myeloid leukemia
Hematology 2025cited by 2position: middledoi
Prognostic value of HSP27 in 28-day mortality in septic ICU patients: a retrospective cohort study
Frontiers in Medicine 2025cited by 1position: middledoi
Autophagy crosstalk with the immune microenvironment in chronic myeloid leukemia and serves as a biomarker for diagnosis and progression
Frontiers in Immunology 2025cited by 1position: middledoi
Machine learning-driven glycolytic subtyping and exosome-based PKM splicing modulation overcome drug resistance in hyper-glycolytic myeloid leukemia
npj Digital Medicine 2025cited by 1position: middledoi
CD8 + T cell-based molecular subtypes with heterogeneous immune landscapes and clinical significance in acute myeloid leukemia
Inflammation Research 2024cited by 8position: middledoi
Identification and validation of hub genes and molecular classifications associated with chronic myeloid leukemia
Frontiers in Immunology 2024cited by 7position: middledoi
High Expression of SRSF10 Promotes Colorectal Cancer Progression by Aberrant Alternative Splicing of RFC5
Technology in Cancer Research & Treatment 2024cited by 5position: middledoi
A Novel Necroptosis-Related Signature Can Predict Prognosis and Chemotherapy Sensitivity in Multiple Myeloma
Technology in Cancer Research & Treatment 2024cited by 4position: middledoi
The m6A regulator KIAA1429 stabilizes RAB27B mRNA and promotes the progression of chronic myeloid leukemia and resistance to targeted therapy
Genes & Diseases 2023cited by 14position: firstdoi
Molecular subtypes predict therapeutic responses and identifying and validating diagnostic signatures based on machine learning in chronic myeloid leukemia
Cancer Cell International 2023cited by 13position: middledoi
Splicing factor-mediated regulation patterns reveals biological characteristics and aid in predicting prognosis in acute myeloid leukemia
Journal of Translational Medicine 2023cited by 9position: middledoi
Bioinformatic analysis of the expression profile and identification of RhoGDI2 as a biomarker in imatinib-resistant K562 cells
Hematology 2023cited by 4position: middledoi
m6A-related lncRNAs predict prognosis and indicate immune microenvironment in acute myeloid leukemia
Scientific Reports 2022cited by 29position: middledoi
Expression and clinical significance of the m6A reader <i>YTHDF2</i> in peripheral blood mononuclear cells from rheumatoid arthritis patients
Journal of Immunotoxicology 2022cited by 20position: firstdoi
Ferroptosis-related molecular patterns reveal immune escape, inflammatory development and lipid metabolism characteristics of the tumor microenvironment in acute myeloid leukemia
Frontiers in Oncology 2022cited by 20position: middledoi
A novel fatty acid metabolism-related signature identifies features of the tumor microenvironment and predicts clinical outcome in acute myeloid leukemia
Lipids in Health and Disease 2022cited by 13position: middledoi
Bioinformatics analysis and identification of hub genes and immune-related molecular mechanisms in chronic myeloid leukemia
PeerJ 2022cited by 10position: firstdoi
Additional file 2 of A novel fatty acid metabolism-related signature identifies features of the tumor microenvironment and predicts clinical outcome in acute myeloid leukemia
Open MIND 2022cited by 0position: middledoi
m(6)A Modification of lncRNA NEAT1 Regulates Chronic Myelocytic Leukemia Progression via miR-766-5p/CDKN1A Axis
Frontiers in Oncology 2021cited by 43position: firstdoi
Quantitative Proteomic Analysis of Plasma Exosomes to Identify the Candidate Biomarker of Imatinib Resistance in Chronic Myeloid Leukemia Patients
Frontiers in Oncology 2021cited by 33position: middledoi
Circular RNAs hsa-circ0000175 and hsa-circ0044235 in plasma are novel biomarkers for new-onset rheumatoid arthritis
Autoimmunity 2021cited by 14position: middledoi
Up-regulation of circRNA-0003528 promotes mycobacterium tuberculosis associated macrophage polarization via down-regulating miR-224-5p, miR-324-5p and miR-488-5p and up-regulating CTLA4
Aging 2020cited by 52position: middledoi
Microarray Expression Profile of Circular RNAs in Peripheral Blood Mononuclear Cells from Active Tuberculosis Patients
Cellular Physiology and Biochemistry 2018cited by 66position: middledoi
Serum PGLYRP‑1 is a highly discriminatory biomarker for the diagnosis of rheumatoid arthritis
Molecular Medicine Reports 2018cited by 29position: middledoi
Circulating circular RNAs hsa_circ_0001204 and hsa_circ_0001747 act as diagnostic biomarkers for active tuberculosis detection.
PubMed 2018cited by 25position: middle
Identification of Differentially Expressed Long Non-coding RNAs in Polarized Macrophages
Scientific Reports 2016cited by 80position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Fangmin Zhong · Nanchang University21 papers (2021–2025)Xiaozhong Wang · Nanchang University14 papers (2021–2025)Junyao Jiang · Nanchang University12 papers (2021–2025)Bo Huang · Chongqing University11 papers (2021–2025)Ying Cheng · Yunnan University7 papers (2022–2023)Mei‐Yong Li · Nanchang University7 papers (2021–2023)Qing Luo · Jiangnan University7 papers (2016–2022)Jing Liu · First Affiliated Hospital of Guangzhou Medical University7 papers (2021–2025)Xiaozhong Wang · Shantou Central Hospital7 papers (2022–2025)Junming Li · China Three Gorges University7 papers (2016–2022)Meiyong Li · Nanchang University5 papers (2022–2025)Shuqi Li · Ministry of Education5 papers (2022–2025)Zikun Huang · Nanchang University5 papers (2016–2020)Rigu Su · Nanchang University4 papers (2018–2020)Shuai Xu · Nanchang University4 papers (2021–2023)Bo Huang · Nanchang University4 papers (2024–2025)Jing Liu · Zhejiang Chinese Medical University3 papers (2021–2025)Jianqing Xu · Weifang Medical University3 papers (2018–2020)Yu‐Lin Yang · Nanchang University3 papers (2021–2023)Lin Jin · Nanchang University3 papers (2022–2022)